Epidermal growth factor-expressing Lactococcus lactis enhances intestinal development of early-weaned pigs

Journal of Nutrition

Volumn 140, Issue 4, 2010, Pages 806-811

  Kang, Ping ^a,b   Toms, Derek ^a   Yin, Yulong ^b   Cheung, Queenie ^a   Gong, Joshhua ^a,c   De Lange, Kees ^a   Li, Julang ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXPRESSION VECTOR; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINE VILLUS; LACTOCOCCUS LACTIS; NONHUMAN; PROTEIN EXPRESSION; SWINE;

ANIMALS; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, BACTERIAL; INTESTINES; LACTOCOCCUS LACTIS; SWINE; WEANING;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; MUS; SUIDAE;

EID: 77949666854     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.114173     Document Type: Article

References (42)

1. Gu X, Li D, She R. Effect of weaning on small intestinal structure and function in the piglet. Arch Tierernahr. 2002;56:275-86.
2. Etheridge RD, Seerley RW, Wyatt RD. The effect of diet on performance, digestibility, blood composition and intestinal microflora of weaned pigs. J Anim Sci. 1984;58:1396-402.
3. Jaeger LA, Lamar CH, Cline TR, Cardona CJ. Effect of orally administered epidermal growth factor on the jejunal mucosa of weaned pigs. Am J Vet Res. 1990;51:471-4.
4. James PS, Smith MW, Tivey DR, Wilson TJ. Epidermal growth factor selectively increases maltase and sucrase activities in neonatal piglet intestine. J Physiol. 1987;393:583-94.
5. Donovan SM, Zijlstra RT, Odle J. Use of the piglet to study the role of growth factors in neonatal intestinal development. Endocr Regul. 1994; 28:153-62.
6. Drouault S, Corthier G, Ehrlich SD, Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol. 1999;65:4881-6.
7. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352-5.
8. Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun. 1998;66:3183-9.
9. Steidler L,Wells JM, Raeymaekers A, Vandekerckhove J, FiersW, Remaut E. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol. 1995;61:1627-9.
10. Cheung QC, Yuan Z, Dyce PW, Wu D, DeLange K, Li J. Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice. Am J Clin Nutr. 2009;89:871-9.
11. NRC. Subcommittee on swine nutrition. Nutrient requirements of swine. 10th rev. ed. Washington, DC: National Academy Press; 1998.
12. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem. 2003;51:1681-8.
13. Verstegen MW, Williams BA. Alternatives to the use of antibiotics as growth promoters for monogastric animals. Anim Biotechnol. 2002;13:113-27.
14. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol. 1965;12:394-407.
15. Dignass AU, Sturm A. Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol. 2001;13:763-70.
16. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 1995;108:564-80.
17. Playford RJ, Wright NA. Why is epidermal growth factor present in the gut lumen? Gut. 1996;38:303-5.
18. Thompson JF. Specific receptors for epidermal growth factor in rat intestinal microvillus membranes. Am J Physiol. 1988;254:G429-35.
19. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut. 1996;39:262-6.
20. Kelly D, McFadyen M, King TP, Morgan PJ. Characterization and autoradiographic localization of the epidermal growth factor receptor in the jejunum of neonatal and weaned pigs. Reprod Fertil Dev. 1992;4:183-91.
21. Buchmiller TL, Shaw KS, Chopourian HL, Lloyd KC, Gregg JP, Rivera FA Jr, Lam ML, Diamond JM, Fonkalsrud EW. Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. J Pediatr Surg. 1993;28:1239-44.
22. Ulshen MH, Lyn-Cook LE, Raasch RH. Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology. 1986;91:1134-40.
23. Shen WH, Xu RJ. Stability of epidermal growth factor in the gastrointestinal lumen of suckling and weaned pigs. Life Sci. 1996;59:197-208.
24. Klijn N, Weerkamp AH, de Vos WM. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol. 1995;61:2771-4.
25. Pryde SE, Richardson AJ, Stewart CS, Flint HJ. Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen, and cecal lumen of a pig. Appl Environ Microbiol. 1999;65:5372-7.
26. Du Toit M, Dicks LM, Holzapfel WH. Taxonomy of obligately homofermentative and facultatively heterofermentative lactobacilli in pig faeces. Lett Appl Microbiol. 2001;32:199-204.
27. Vaughan EE, de Vries MC, Zoetendal EG, Ben-Amor K, Akkermans AD, de Vos WM. The intestinal LABs. Antonie Van Leeuwenhoek. 2002;82:341-52.
28. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107-33.
29. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137:S781-90.
30. Furuse M, Okumura J. Nutritional and physiological characteristics in germ-free chickens. Comp Biochem Physiol A Physiol. 1994;109:547-56.
31. Shirkey TW, Siggers RH, Goldade BG, Marshall JK, Drew MD, Laarveld B, Van Kessel AG. Effects of commensal bacteria on intestinal morphology and expression of proinflammatory cytokines in the gnotobiotic pig. Exp Biol Med (Maywood). 2006;231:1333-45.
32. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol. 1997;63:513-8.
33. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol. 2003;17:741-54.
34. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003;16:658-72.
35. Doyle M. Alternatives to antibiotic use for growth promotion in animal husbandry. FRI Briefings. Madison (WI): Food Research Institute, University of Wisconsin; 2001.
36. Kremer B. DFM products provide consistent outcomes. Feedstuffs. 2006;24.
37. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics. 2005;115:5-9.
38. Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol. 2005;68:705-17.
39. Buret A, Olson ME, Gall DG, Hardin JA. Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits. Infect Immun. 1998;66:4917-23.
40. Buret A, Gall DG, Olson ME, Hardin JA. The role of the epidermal growth factor receptor in microbial infections of the gastrointestinal tract. Microbes Infect. 1999;1:1139-44.
41. Elliott SN, Wallace JL, McKnight W, Gall DG, Hardin JA, Olson M, Buret A. Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am J Physiol Gastrointest Liver Physiol. 2000;278:G105-12.
42. Lamb-Rosteski JM, Kalischuk LD, Inglis GD, Buret AG. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation. Infect Immun. 2008;76:3390-8.